公司在布里斯托尔·迈尔斯·斯奎布 (Bristol Myers Squibb) 购买了2400万美元的股份, 报告收益较低, 但提高了2026年的预期, 并提高了股息. Quadrature Capital bought a $24M stake in Bristol Myers Squibb, which reported lower earnings but raised 2026 guidance and raised its dividend.

四方资本有限公司在布里斯托尔·迈尔斯·斯奎布(BMY)收购了2 401万美元的股份,购买了532 436股,而Mackenzie金融公司将持有的股份增加到125万股,价值5 658万美元。 Quadrature Capital Ltd acquired a $24.01 million stake in Bristol Myers Squibb (BMY), buying 532,436 shares, while Mackenzie Financial Corp increased its holding to 1.25 million shares, valued at $56.58 million. BMY报告第三季度收入为每股1.26美元,低于1.65美元的估计数,尽管收入逐年增长1.3%,达到12.50亿美元。 BMY reported third-quarter earnings of $1.26 per share, below the $1.65 estimate, though revenue rose 1.3% year-over-year to $12.50 billion. 该公司将其2026年全年收入指导提高到每股6.05-6.35美元,并宣布季度股息为0.63美元,收益率为4.3%。 The company raised its 2026 full-year earnings guidance to $6.05–6.35 per share and declared a quarterly dividend of $0.63, yielding 4.3%. 股市上限为1200亿美元,低比特为0.26美元,股票交易接近12个月的62.89美元,得到混合分析师评级和协商一致的“坚持”支持,目标为61.00美元。 With a market cap of $120 billion and a low beta of 0.26, the stock trades near its 12-month high of $62.89, supported by mixed analyst ratings and a consensus "Hold" with a $61.00 target.